288 related articles for article (PubMed ID: 22163178)
1. Protease-resistant prions selectively decrease Shadoo protein.
Watts JC; Stöhr J; Bhardwaj S; Wille H; Oehler A; Dearmond SJ; Giles K; Prusiner SB
PLoS Pathog; 2011 Nov; 7(11):e1002382. PubMed ID: 22163178
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation.
Westaway D; Genovesi S; Daude N; Brown R; Lau A; Lee I; Mays CE; Coomaraswamy J; Canine B; Pitstick R; Herbst A; Yang J; Ko KW; Schmitt-Ulms G; Dearmond SJ; McKenzie D; Hood L; Carlson GA
PLoS Pathog; 2011 Nov; 7(11):e1002391. PubMed ID: 22114562
[TBL] [Abstract][Full Text] [Related]
3. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc.
Pirisinu L; Di Bari M; Marcon S; Vaccari G; D'Agostino C; Fazzi P; Esposito E; Galeno R; Langeveld J; Agrimi U; Nonno R
PLoS One; 2010 Sep; 5(9):e12723. PubMed ID: 20856860
[TBL] [Abstract][Full Text] [Related]
4. Function of Prion Protein and the Family Member, Shadoo.
Onodera T; Nishimura T; Sugiura K; Sakudo A
Curr Issues Mol Biol; 2020; 36():67-88. PubMed ID: 31559969
[TBL] [Abstract][Full Text] [Related]
5. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections.
Watts JC; Drisaldi B; Ng V; Yang J; Strome B; Horne P; Sy MS; Yoong L; Young R; Mastrangelo P; Bergeron C; Fraser PE; Carlson GA; Mount HT; Schmitt-Ulms G; Westaway D
EMBO J; 2007 Sep; 26(17):4038-50. PubMed ID: 17703189
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
7. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
Shoup D; Priola SA
Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
[TBL] [Abstract][Full Text] [Related]
8. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Shadoo and PrP Affects the PrP-Folding Pathway.
Ciric D; Richard CA; Moudjou M; Chapuis J; Sibille P; Daude N; Westaway D; Adrover M; Béringue V; Martin D; Rezaei H
J Virol; 2015 Jun; 89(12):6287-93. PubMed ID: 25855735
[TBL] [Abstract][Full Text] [Related]
10. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
[TBL] [Abstract][Full Text] [Related]
11. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
12. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
13. Endoproteolytic processing of the mammalian prion glycoprotein family.
Mays CE; Coomaraswamy J; Watts JC; Yang J; Ko KW; Strome B; Mercer RC; Wohlgemuth SL; Schmitt-Ulms G; Westaway D
FEBS J; 2014 Feb; 281(3):862-76. PubMed ID: 24286250
[TBL] [Abstract][Full Text] [Related]
14. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
15. Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain.
Mahal SP; Jablonski J; Suponitsky-Kroyter I; Oelschlegel AM; Herva ME; Oldstone M; Weissmann C
PLoS Pathog; 2012; 8(6):e1002746. PubMed ID: 22685404
[TBL] [Abstract][Full Text] [Related]
16. Wild-type Shadoo proteins convert to amyloid-like forms under native conditions.
Daude N; Ng V; Watts JC; Genovesi S; Glaves JP; Wohlgemuth S; Schmitt-Ulms G; Young H; McLaurin J; Fraser PE; Westaway D
J Neurochem; 2010 Apr; 113(1):92-104. PubMed ID: 20067571
[TBL] [Abstract][Full Text] [Related]
17. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells.
Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K
J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286
[TBL] [Abstract][Full Text] [Related]
18. The protease-sensitive N-terminal polybasic region of prion protein modulates its conversion to the pathogenic prion conformer.
Zhang X; Pan YH; Chen Y; Pan C; Ma J; Yuan C; Yu G; Ma J
J Biol Chem; 2021 Nov; 297(5):101344. PubMed ID: 34710372
[TBL] [Abstract][Full Text] [Related]
19. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
20. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
Hara H; Sakaguchi S
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
